Trial intelligence / Profile preview

Nitric oxide treatment during knee prosthesis surgery

2008-006776-29Phase 2Active

Sponsor
Karolinska Institutet
Start
Nov 2008
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of nitric oxide in knee osteoarthritis (OA), sponsored by Karolinska Institutet. Primary endpoint: Inflammatory markers in blood and muscle. Started Nov 2008; status: active.

02

Drugs

nitric oxide
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on 2008-006776-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-006776-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call